PCPriyaRasipuram Chandrasekaran

PriyaRasipuram Chandrasekaran

*This is an algorithmically generated author record based on publicly available information.

PriyaRasipuram Chandrasekaran has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Role of microperimetry to detect early visual function deficits in patients with hydroxychloroquine retinal toxicity—a review

    by Priya R. Chandrasekaran, Anna C. S. Tan

    Chloroquine and its analogue hydroxychloroquine (HCQ) are antimalarial drugs used in various rheumatological and dermatological diseases. HCQ retinal toxicity (HCQ-RT) is uncommon but early detection of retinal toxicity and prompt cessation of the medication can usually prevent significant visual function (VF) losses. The risk of retinopathy from HCQ depends on the duration of drug use, cumulative exposure to the drug, age, presence of liver or renal disease and underlying retinal disease. The screening of all patients on HCQ for early detection of retinal toxicity is recommended. Routine screening tests include structural imaging with spectral domain optical coherence tomography and fundus autofluorescence and functional testing with visual fields and electrophysiology. Functional testing is challenging as it requires patient co-operation. No single test has shown high sensitivity or specificity. Microperimetry (MP) is an emerging VF measure that allows the evaluation of mesopic and scotopic macular sensitivity by the detection of early scotomas and a change in normal fixation. It employs computerized threshold perimetry with real-time fundus imaging. This is a scoping review of the literature to provide updates on recent studies that have used MP as an ancillary diagnostic test for detecting HCQ toxicity in the retina.

  • Optical Coherence Tomography and Optical Coherence Tomography-Angiography

    by Niroj Kumar Sahoo, Priya R. Chandrasekaran, Ninan Jacob, Gemmy Cheung

  • Open Access

    A case of secondary multiple evanescent white dot syndrome in a patient with preexisting wet age-related macular degeneration

    by Priya R. Chandrasekaran, Hiok Hong Chan, Tien-En Tan, Farah N.I. Ibrahim, Jinzhi Zhao, Kelvin Y.C. Teo


  • Open Access

    Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy

    by Kai Xiong Cheong, Charles Jit Teng Ong, Priya R Chandrasekaran, Jinzhi Zhao, Kelvin Yi Chong Teo, Ranjana Mathur

    This review provides an overview of conventional and novel retinal imaging modalities for hydroxychloroquine (HCQ) retinopathy. HCQ retinopathy is a form of toxic retinopathy resulting from HCQ use for a variety of autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Each imaging modality detects a different aspect of HCQ retinopathy and shows a unique complement of structural changes. Conventionally, spectral-domain optical coherence tomography (SD-OCT), which shows loss or attenuation of the outer retina and/or retinal pigment epithelium–Bruch’s membrane complex, and fundus autofluorescence (FAF), which shows parafoveal or pericentral abnormalities, are used to assess HCQ retinopathy. Additionally, several variations of OCT (retinal and choroidal thickness measurements, choroidal vascularity index, widefield OCT, en face imaging, minimum intensity analysis, and artificial intelligence techniques) and FAF techniques (quantitative FAF, near-infrared FAF, fluorescence lifetime imaging ophthalmoscopy, and widefield FAF) have been applied to assess HCQ retinopathy. Other novel retinal imaging techniques that are being studied for early detection of HCQ retinopathy include OCT angiography, multicolour imaging, adaptive optics, and retromode imaging, although further testing is required for validation.


  • Open Access

    New Concepts for the Diagnosis of Polypoidal Choroidal Vasculopathy

    by Jinzhi Zhao, Priya R Chandrasekaran, Kai Xiong Cheong, Mark Wong, Kelvin Teo

    Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (nAMD) that is characterized by a branching neovascular network and polypoidal lesions. It is important to differentiate PCV from typical nAMD as there are differences in treatment response between subtypes. Indocyanine green angiography (ICGA) is the gold standard for diagnosing PCV; however, ICGA is an invasive detection method and impractical for extensive use for regular long-term monitoring. In addition, access to ICGA may be limited in some settings. The purpose of this review is to summarize the utilization of multimodal imaging modalities (color fundus photography, optical coherence tomography (OCT), OCT angiography (OCTA), and fundus autofluorescence (FAF)) in differentiating PCV from typical nAMD and predicting disease activity and prognosis. In particular, OCT shows tremendous potential in diagnosing PCV. Characteristics such as subretinal pigment epithelium (RPE) ring-like lesion, en face OCT-complex RPE elevation, and sharp-peaked pigment epithelial detachment provide high sensitivity and specificity for differentiating PCV from nAMD. With the use of more practical, non-ICGA imaging modalities, the diagnosis of PCV can be more easily made and treatment tailored as necessary for optimal outcomes.


  • Open Access

    Cooling Anesthesia for Intravitreal Injections – A Review

    by Priya R Chandrasekaran, Aamir A Aziz, Hannah Khan, Arshad M Khanani

    Intravitreal (IVT) injections are the most common procedure performed in retinal clinics today. It has revolutionized the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema, macular edema due to veinous occlusive disease and other forms of exudative maculopathy. Though IVT injections prevent vision loss, the discomfort at the time of the injection has been troublesome to patients. This has led to patients missing their regular and routine dosage of treatment. Various modes of pre-injection anesthetic methods have been tried but in vain. Lidocaine-based topical anesthesia, in the form of pledgets, topical gel or subconjunctival lidocaine injection, has been the standard of care (SOC) for IVT injections worldwide. This article highlights the role of cooling anesthesia in reducing pain, anxiety and discomfort associated with needle penetration at the time of injection. PubMed and MedLine search were related to anesthesia for intravitreal injections, cooling anesthesia, mechanism of cooling anesthesia, COOL-1 trial, COOL-2 trial, results of COOL-1 trial and ultrarapid cooling anesthesia.


  • A Curious Case of Occlusive Retinal Vasculitis in a Young Individual Associated with COVID-19 Vaccination

    by Priya R. Chandrasekaran

    A 23-year-old man presented with the blurring of vision in the left eye for 4 days. Best-corrected visual acuity was 6/6 N6 in both eyes. Examination revealed an unremarkable right eye while the left eye showed occlusive retinal vasculitis with no retinitis, choroiditis, or macular involvement. Fundus fluorescein angiography confirmed the same. History revealed the patient had received 2nd dose of Covishield vaccination 4 weeks before the onset of symptoms. Blood investigations were negative for infectious or any systemic autoimmune disease. Serum homocysteine and serum CMV IgG levels were grossly increased while tests for antiphospholipid syndrome were weakly positive. He responded well to a combination of intravitreal and oral antivirals, oral steroids for vasculitis and tablets Clopilet and Homin. This case is extremely intriguing in terms of the involvement of the adenoviral vector vaccine either as a causative factor or being just a coincidental finding.


  • Role of Curcumin in Retinal Diseases—A review

    by Priya R. Chandrasekaran, V. G. Madanagopalan

    Purpose To review the role of curcumin in retinal diseases, COVID era, modification of the molecule to improve bioavailability and its future scope. Methods PubMed and MEDLINE searches were pertaining to curcumin, properties of curcumin, curcumin in retinal diseases, curcumin in diabetic retinopathy, curcumin in age-related macular degeneration, curcumin in retinal and choroidal diseases, curcumin in retinitis pigmentosa, curcumin in retinal ischemia reperfusion injury, curcumin in proliferative vitreoretinopathy and curcumin in current COVID era. Results In experimental models, curcumin showed its pleiotropic effects in retinal diseases like diabetic retinopathy by increasing anti-oxidant enzymes, upregulating HO-1, nrf2 and reducing or inhibiting inflammatory mediators, growth factors and by inhibiting proliferation and migration of retinal endothelial cells in a dose-dependent manner in HRPC, HREC and ARPE-19 cells. In age-related macular degeneration, curcumin acts by reducing ROS and inhibiting apoptosis inducing proteins and cellular inflammatory genes and upregulating HO-1, thioredoxin and NQO1. In retinitis pigmentosa, curcumin has been shown to delay structural defects of P23H gene in P23H-rhodopsin transgenic rats. In proliferative vitreoretinopathy, curcumin inhibited the action of EGF in a dose- and time-dependent manner. In retinal ischemia reperfusion injury, curcumin downregulates IL-17, IL-23, NFKB, STAT-3, MCP-1 and JNK. In retinoblastoma, curcumin inhibits proliferation, migration and apoptosis of RBY79 and SO-RB50. Curcumin has already proven its efficacy in inhibiting viral replication, coagulation and cytokine storm in COVID era. Conclusion Curcumin is an easily available spice used traditionally in Indian cooking. The benefits of curcumin are manifold, and large randomized controlled trials are required to study its effects not only in treating retinal diseases in humans but in their prevention too.


  • Open Access

    Spectral domain optical coherence tomographic findings in Welder's maculopathy

    by PriyaRasipuram Chandrasekaran

    Aled orange-red spot surrounded by a pigmentary halo. The corresponding SD OCT showed a rectangular-shaped solitary hyporeflective space called the outer retinal hole. The hole extends from the inner layer of the retinal pigment epithelium to external limiting membrane, which in turn corresponds to inner segment/outer segment photo receptor junction (IS/OS). The straight edges of the hole and the top surface at the level of IS/OS junction line are lined by hyperreflective material. Central subfield thickness was 205 μm and 209 μm, respectively. SD OCT findings were similar to photic/solar maculopathy....

  • Open Access

    Ranibizumab port delivery system in neovascular age-related macular degeneration

    by Priya R. Chandrasekaran, V.G. Madanagopalan

    Ranibizumab has proven its efficacy in various retinal diseases and particularly in neovascular age-related macular degeneration (nAMD). The number of injections and the frequent follow-up visits has been burdensome to patients particularly during the COVID era. Ranibizumab port delivery system (RPDS) seems to be a boon in prolonging the action of the drug without the need for frequent injections and follow-up visits. This review article highlights the dosage, adverse effects, and visual outcome associated with various trials of RPDS. For this article, we conducted a PubMed search and review of literature on nAMD, the incidence of AMD, anti-vascular endothelial growth factor (anti-VEGF) agents, RPDS, phase-1 trial of RPDS, phase-2 (LADDER trial) of RPDS, phase-3 (ARCHWAY trial) of RPDS, PORTAL trial of RPDS, results of phase-1 trial of RPDS, results of phase-2 (LADDER) trial of RPDS, and results of phase-3 (ARCHWAY) trial of RPDS.